Tag: company

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) --

WHY: New York, N.Y., June 14, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

WINNIPEG, Manitoba, June 13, 2025 (GLOBE NEWSWIRE) -- (TSX Symbol: NWC): The North West Company Inc. (the “Company” or “North West”) today announced that shareholders voted in favour of all items of business put forth by the Company at its annual general meeting of shareholders held on June 11, 2025, including the election of all the nominee directors listed in the Notice of Meeting and Management Information Circular dated April 9, 2025:

The acquisition by Heimar hf. ("Heimar" or the "Company") of all shares in Gróska ehf. (“Gróska”) and Gróðurhúsið ehf. (“Gróðurhúsið”) (the “Transaction”), which was initially announced on 23 April this year, has now been completed. 

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that dosing has commenced at the prestigious Weill Cornell Medicine Multiple Sclerosis Center in New York City, in its ongoing Phase 2 clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). This fifth site complements existing sites at Yale University, Johns Hopkins University, Brigham and Women's Hospital, and the University of Massachusetts.

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.

GREENWICH, Conn., June 13, 2025 (GLOBE NEWSWIRE) -- Leverage Shares by Themes, an issuer of innovative exchange-traded products, is excited to announce the launch of the Leverage Shares 2X long BA Daily ETF (ticker: BOEG), a new single stock leveraged ETF, available for trading starting June 13, 2025 on Nasdaq. The product is designed to equip investors to amplify returns (up and down) and dynamically participate in the performance of a leading transportation and aerospace company. The new ETF is tailored to target a 200% exposure to the daily performance of its underlying stock, Boeing Co. (BA), offering sophisticated traders and the retail investor an efficient tool to capitalize on market movements at an industry low management fee for single stock leveraged ETFs at .75%.